Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma

British Journal of Cancer

Volumn 71, Issue 6, 1995, Pages 1257-1262

  Mulder, J W R ^a   Baas, I O ^a   Polak, M M ^a   Goodman, S N ^b   Offerhaus, G J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Carcinoma; Colorectal; Long term; P53; Prognosis

Indexed keywords

ANTIGEN; GENE PRODUCT; MARKER; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; COHORT STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN P53; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0029023358     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.243     Document Type: Article

References (49)

1. DE ANGELIS, P., STOKKE, T., SMEDSHAMMER, L., LOTHE, RA., MEUNG, GI., ROFSTAD, M., CHEN, Y., AND CLAUSEN, OPF. (1993). p53 expression is associated with a high degree of tumor DNA aneuploidy and incidence of p53 gene mutation, and is localized to the aneuploid component in colorectal carcinomas. Int. J. Oncol., 3, 305–312.
2. BAAS, IO., MULDER, JWR., OFFERHAUS, GJA., VOGELSTEIN, B., AND HAMILTON, SR. (1994). An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172, 5–12.
3. BAKER, SJ., FEARON, ER., NIGRO, JM., HAMILTON SR, PREISINGER AC, JESSUP, JM., VAN TUINEN, P., LEDBETTER, DH., BARKER, DF., NAKAMURA, Y., WHITE, R., AND VOGELSTEIN, B. (1989). Chromosome 17p deletions and p53 gene mutations in colorectal carcinomas. Science, 244, 217–221.
4. BAKER, SJ., PREISINGER, AC., JESSUP, M., PARASKEVA, C., MARKOWITZS, S., WILLSON, JKV., HAMILTON, S., AND VOGELSTEIN, B. (1990).p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717–7722.
5. BARNES, DM., DUBLIN, EA., FISHER, CJ., LEVISON, DA., AND MILLIS, RR. (1993). Immunohistological detection of p53 in mammary carcinoma: an important new independent indicator of prognosis? Hum. Pathol., 24, 469–476.
6. BELL, SM., SCOTT, N., CROSS, D., SAGAR, P., LEWIS, FA., BLAIR, GE., TAYLOR, GR., DIXON, MF., AND QUIRKE, P. (1993). Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology, 104, 57–64.
7. VAN DEN BERG, FM., BAAS, IO., POLAK, MM., AND OFFERHAUS, GJA. (1993). Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am. J. Pathol., 142, 381–385.
8. BLOEM R. (1983). Colorectal carcinoma. Dissertation, University of Leiden. The Netherlands.
9. BOSARI, S., VIALE, G., RADAELLI, U., BOSSI, P., BONOLDI, E., AND COGGI, G. (1993). p53 accumulation in ovarian carcinomas and its prognostic implications. Hum. Pathol., 24, 1175–1179.
10. BOSARI, S., VIALE, G., BOSSI, P., MAGGIONI, M., COGGI, G., MURRAY, JJ., AND LEE, AKC. (1994). Cytoplasmatic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl Cancer. Inst., 86, 681–687.
11. CAMPO, E., DE LA CALLE-MARTIN, O., MIQUEL, R., PALACIN, A., ROMERO, M., FABREGAT, V., VIVES, J., CARDESA, A., AND YAGUE, J.(1991). Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51, 4436 -4442.
12. DIGUISEPPE, JA., HRUBAN, RH., GOODMAN, SN., ALLISON, DA., CAMERON, JL., AND OFFERHAUS, GJA. (1994). Overexpression of the p53 tumor suppressor protein in pancreatic adenocarcinoma. Am. J. Clin. Pathol., 101, 684–688.
13. DUKES CE. (1932). The classification of cancer of the rectum. J. Pathol. Bacteriol., 35, 323–332.
14. EL-DEIRY, WS., TOKINO, T., VELCULESCU, VE., LEVY, DB., PARSONS, R., TRENT, JM., LIN, D., MERCER, WE., KINZLER, KW., AND VOGELSTEIN, B. (1993). WAF1. a potential mediator of p53 tumor suppression. Cell, 75, 817–825.
15. ENOMOTO, T., WEGHORST, CM., INOUE, M., TANIZAWA, O., AND RICE, JM. (1991). K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am. J. Pathol., 139, 777–785.
16. FINLAY, CA., HINDS, PW., TAN, TH., ELIYAHU, D., OREN M., AND LEVINE AJ. (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc700-p53 complex with an altered half-life. Mol. Cell. Biol., 8, 531–539.
17. GRAHAM, DM., AND APPELMAN, HD. (1990). Crohns-like lymphoid reaction and colorectal carcinomas: a potential histologic prognosticator. Modern Pathol. 3, 332–335.
18. HALL, PA., AND LANE, DP., (1994). p53 in tumour pathology: can we trust immunohistochemistry? revisited! J. Pathol. 172, 1–4.
19. HAMELIN, R., LAURENT-PUIG, P., OLSCHWANG, S., JEGO, N., ASSELAIN, B., REMVIKOS, Y., GIRODET, J., SALMON, RJ., AND THOMAS, G., (1994). Association of p53 mutations with short survival in colorectal cancer. Gastroenterology. 106, 42–48.
20. HANSKI, C., BORNHOEFT, G., SHIMODA, T., HANSKI, M.-L., LANE, DP., STEIN, H., AND RIECKEN, E.-O. (1992). Expression of p53 protein in invasive colorectal carcinomas of different histologic types. Cancer. 70, 2772–2777.
21. JASS JR. (1986). Lymphocytic infiltration and survival in rectal cancer. J. Clin. Pathol. 39, 585–589.
22. KAKLAMANIS, L., GATTER, KC., MORTENSEN, N., BAIGRIE, RJ., HERYET, A., LANE, DP., AND HARRIS, AL., (1993). p53 expression in colorectal adenomas. Am. J. Pathol. 142, 87–93.
23. KERN, SE., FEARON, ER., TERSMETTE, KWF., ENTERLINE, JP., LEPPERT, M., NAKAMURA, Y., WHITE, R., VOGELSTEIN, B., AND HAMILTON, SR. (1989). Clinical and pathological associations with allelic loss in colorectal carcinoma. J. Am. Med. Assoc. 261, 3099–3103.
24. KERN, SE., PIETENPOL, JA., THIAGALINGAM, S., SEYMOUR, A., KINZLER, KW., AND VOGELSTEIN, B., (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827–830.
25. LANE, DP. (1992). p53, guardian of the genome. Nature, 358, 15–16.
26. LAURENT-PUIG, P., OLSCHWANG, S., DELATTRE, O., VALIDIRE, P., MELOT, T., MOSSERI, V., SALMON, RJ., AND THOMAS, G., (1991). Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma. Int. J. Cancer, 49, 220–223.
27. LAURENT-PUIG, P., OLSCHWANG, S., DELATTRE, O., REMVIKOS, V., ASSELAIN, B., MELOT, T., VALIDIRE, P., MULERIS, M., GIRODET, J., SALMON, RJ., AND THOMAS, G., (1992). Survival and acquired genetic alterations in colorectal cancer. Gastroenterology, 102, 1136-1141.’
28. LEVINE AJ. (1992a). The p53 tumor-suppressor gene. N. Engl. J. Med. 326, 1350–1351.
29. LEVINE AJ. (1992b). The p53 tumor suppressor gene and product. Cancer Surx. 12, 59–80.
30. MARTIN, HM., FILIPLE, MI., MORRIS, RW., LANE, DP., AND SILVESTRE, F., (1992). p53 expression and prognosis in gastric carcinoma. Int. J. Cancer, 50, 859–862.
31. MECKLIN, JP., SIPPONEN, P., AND JARVINEN, HJ. (1986). Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis. Colon Rectum, 29, 849–853.
32. MUKAI, K., ROSAI, J., AND BURGDORF, WHC., (1980). Localization of factor VUI-related antigen in vascular endothelial cells using an immunoperoxidase method. Am. J. Surg. Pathol., 4, 273–276.
33. MULDER, JWR., WIELENGA, VJM., POLAK, MM., VAN DEN BERG, FM., ADOLF, GR., HERRLICH, P., PALS, ST., AND OFFERHAUS, GJA., (1995). Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut, 36, 76–80.
34. MULLER, S., CHESNER, IM., EGAN, MJ., ROWLANDS, DC., COLLARD, MJ., SWARBRICK, ET., AND NEWMAN, J., (1989). Significance of venous and lymphatic invasion in malignant polyps of the colon and rectum. Gut. 30, 1385–1391.
35. NATHANSON, SD., LINDEN, MD., TENDER, P., ZARBO, RJ., JACOBSON, G., AND NELSON, LS., (1994). Relationship among p53, stage, and prognosis of large bowel cancer. Dis. Colon Rectum, 37, 527–534.
36. OFFERHAUS, GJA., GIARDIELLO, FM., BRUIJN, JA., STUNEN, T., MOLYVAS, EN., AND FLEUREN, GJ., (1991). The value of collagen IV immunohistochemistry in colorectal cancer. Cancer, 67, 99–105.
37. OFFERHAUS, GJA., DE FEYTER, EP., CORNELISSE, CJ., TERSMETTE, KWF., FLOYD, J., KERN, SE., VOGELSTEIN, B., AND HAMILTON, SR.(1992). The relationship of DNA aneuploidv to molecular genetic alterations in colorectal carcinoma. Gastroenterology, 102, 1612–1619.
38. OREN M. (1992). p53 -the ultimate tumor suppressor gene. FASEB. J., 6, 3169–3176.
39. PURDIE, CA., O GRADY, JO., PIRIS, J., WYLLIE, AH., AND BIRD, CC.(1991). p53 expression in colorectal tumors. Am. J. Pathol. 138, 807–813.
40. QUINLAN, DC., DAVIDSON, AG., SUMMERS, CL., WARDEN, HE., AND DOSHI, HM., (1992). Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52, 4828–4831.
41. REMVIKOS, Y., TOMINAGA, O., HAMMEL, P., LAURENT-PUIG, P., SALMON, RJ., DUTRILLAUX, B., AND THOMAS, G., (1992). Increased p53 protein content of colorectal tumours correlates with poor survival. Br. J. Cancer, 66, 758–764.
42. RODRIGUES, NR., ROWAN, A., SMITH, ME., KERR, IB., BODMER, WF., GANNON, JV., AND LANE, DP., (1990). p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555–7559.
43. SCOTT, NP., SAGAR, P., STEWART, J., BLAIR, GE., DIXON, MF., AND QUIRKE, P., (1991). p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br. J. Cancer, 63, 317–319.
44. STARZYNSKA, T., BROMLEY, M., GHOSH, A., AND STERN, PL., (1992). Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br. J. Cancer, 66, 558–562.
45. SUN, X.-F., CARSTENSEN, JM., ZHANG, H., STAL, O., WINGREN, S., HATSCHEK, T., AND NORDENSKJOLD, B., (1992). Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet, 340, 1369–1373.
46. TURNBULL, JRRB., KYLE, K., WATSON, FR., AND SPRATT, J. (1967). Cancer of the colon; the influence of the no-touch isolation technic on survival rates. Ann. Surg., 166, 420–427.
47. VOGELSTEIN, B., AND KINZLER, KW., (1992). p53 function and dysfunction. Cell, 70, 523–526.
48. WYNFORD-THOMAS, D. (1992). p53 in tumour pathology: can we trust immunohistochemistry? J. Pathol., 166, 329 -330.
49. YAMAGUCHI, A., KUROSAKA, Y., FUSHIDA, S., KANNO, M., YONEMURA, Y., MIWA, K., AND MIYAZAKI, I., (1992). Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer, 70, 2778–2784.